| Cash Flow | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Net sales | 318,987 | 347,385 | 342,879 | NaN |
| Cost of sales | 134,372 | 154,103 | 137,490 | NaN |
| Marketing expenses | 79,102 | 75,705 | 79,116 | NaN |
| Selling expenses | 81,693 | 85,533 | 88,314 | NaN |
| General and administrative | 33,592 | 30,654 | 31,792 | NaN |
| Research and development | 5,348 | 6,291 | 7,328 | NaN |
| Restructuring costs | 21,736 | 3,151 | 39,154 | NaN |
| Asset impairment charges | NaN | 0 | NaN | NaN |
| Interest expense | 13,103 | 13,880 | 12,687 | NaN |
| Income tax (expense) benefit | 338 | 36,578 | -13,212 | NaN |
| Loss on impairment of strategic investment asset | NaN | -15,450 | NaN | -775 |
| Net loss | -50,297 | -58,510 | -39,790 | -33,658 |
| Depreciation and amortization | 12,371 | 12,977 | 13,535 | 29,096 |
| Stock-based compensation | 2,826 | 1,570 | -788 | 5,500 |
| Loss on impairment of strategic investment asset | NaN | NaN | 16,134 | NaN |
| Inventory obsolescence write off | 2,099 | 9,565 | NaN | NaN |
| Loss on disposal and impairment of leased assets | -17,539 | -40,072 | 19,753 | NaN |
| Deferred income taxes | 0 | 24,531 | 6,873 | 1,772 |
| Accounts receivable | -2,148 | 1,600 | -2,115 | -1,499 |
| Inventories | -1,918 | 1,967 | -9,619 | -3,702 |
| Income taxes | 482 | 13,889 | -20,737 | 2,470 |
| Prepaid expenses and other assets | 4,266 | -6,730 | 7,222 | -10,381 |
| Accounts payable | 3,818 | 12,516 | 1,803 | 8,354 |
| Customer prepayments | 3,811 | 2,773 | -4,387 | -5,792 |
| Accrued compensation and benefits | 4,354 | -3,622 | -2,405 | -10,086 |
| Other taxes and withholding | -1,003 | -1,111 | 1,534 | -3,235 |
| Other accruals and liabilities | -3,551 | -16,522 | -1,617 | -9,582 |
| Net cash used in operating activities | -7,751 | 1,876 | -6,355 | 1,196 |
| Purchases of property and equipment | 5,441 | 2,519 | 3,836 | 8,052 |
| Payment to secure contractual rights | NaN | NaN | 0 | 3,280 |
| Proceeds from sales of property and equipment | NaN | 0 | 0 | NaN |
| Issuance of notes receivable | NaN | 0 | 0 | 0 |
| Payment to secure contractual rights | NaN | 3,280 | NaN | NaN |
| Net cash used in investing activities | -5,441 | -2,519 | -3,836 | -11,332 |
| Net increase in short-term borrowings | 13,805 | 5,849 | 9,863 | 12,356 |
| Repurchases of common stock | 373 | 194 | 75 | 944 |
| Proceeds from issuance of common stock | NaN | 0 | NaN | NaN |
| Debt issuance costs | 449 | 4,583 | -318 | 1,877 |
| Net cash provided by financing activities | 12,983 | 1,072 | 10,106 | 9,535 |
| Net decrease in cash and cash equivalents | -209 | 429 | -85 | -601 |
| Cash and cash equivalents, at beginning of period | 1,693 | 1,264 | 1,950 | NaN |
| Cash and cash equivalents, at end of period | 1,484 | 1,693 | 1,264 | NaN |
Sleep Number Corp (SNBR)
Sleep Number Corp (SNBR)